Clinical and Molecular Hepatology

"Dorothy Cheuk-Yan Yiu"

Letter to the Editor

Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy: Letter to the editor on “Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?”: Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip; Clin Mol Hepatol 2024;30(4):970-973.
Published online July 4, 2024; DOI: https://doi.org/10.3350/cmh.2024.0280

Citations

Citations to this article as recorded by

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer
Dorothy Cheuk‐Yan Yiu, Jimmy Che‐To Lai, Landon Long Chan, Grace Lai‐Hung Wong, Mandy Sze‐Man Lai, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Stephen Lam Chan, Terry Cheuk‐Fung Yip
Alimentary Pharmacology & Therapeutics.2026; 63(3): 383. CrossRef
Prognostic Impact of DPP4 Inhibitors on Systemic Drug Therapy for Advanced Kidney Cancer Patients
Shuhei Kamada, Sachi Kitayama, Ryosuke Yamase, Kazuhiro Ikeda, Wataru Sato, Tomokazu Sazuka, Hideki Takeshita, Shinichi Sakamoto, Akihiro Yano, Kuniko Horie, Tomohiko Ichikawa, Satoru Kawakami, Satoshi Inoue
Cancer Science.2026; 117(2): 468. CrossRef
CXCL12 as a Potential Hub Gene for N-Acetylcysteine Treatment of T1DM Liver Disease
Menglong Zhao, Mingzheng Han, Shuaihao Guo, Zhaoxin Tang
Biomolecules.2025; 15(2): 176. CrossRef